Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report

Ovarian squamous cell carcinoma arising from mature cystic teratoma is extremely rare. Our study adds to our understanding of this rare but ominous tumor. Herein we report a case of squamous cell carcinoma in a mature cystic teratoma of the right ovary in a 56-year-old woman presenting with pelvic mass and abdominal pain. Histopathological examination after exploratory laparoscopy revealed squamous cell carcinoma arising from an ovarian mature cystic teratoma with appendix invaded. The patient subsequently underwent complete debulking surgery. Unfortunately, the tumour was refractory to combined chemotherapy with docetaxel and oxaliplatin, the patient refused further treatment and passed away six months after the operation.

Chemotherapy; Mature cystic teratoma; Ovary; Squamous cell carcinoma.

[1] Hackethal A., Brueggmann D., Bohlmann M.K., Franke F.E., Tin-neberg H.R., Münstedt K.: ”Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data”. Lancet Oncol., 2008, 9, 1173.

[2] Li C., Zhang Q., Zhang S., Dong R., Sun C., Qiu C., et al.: ”Squa-mous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review”. BMC Cancer, 2019, 19, 217.

[3] Prat J., Belhadj H., Berek J., Bermudez A., Bhatla N., Cain J., et al.: ”Abridged republication of FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum”. Eur. J. Gynaecol. Oncol., 2015, 36, 367.

[4] Saba L., Guerriero S., Sulcis R., Virgilio B., Melis G., Mallarini G.: ”Mature and immature ovarian teratomas: CT, US and MR imaging characteristics”. Eur. J. Radiol., 2009, 72, 454.

[5] Feng X., Xu L.: ”Rare case of squamous cell carcinoma arising in a recurrent ovarian mature cystic teratoma of a young woman: A case report and review of the literature”. Medicine (Baltimore), 2018, 97, e10802.

[6] Chiang A.J., Chen M.Y., Weng C.S., Lin H., Lu C.H., Wang P.H., et al.: ”Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study”. J. Gynecol. Oncol., 2017, 28, e69.

[7] Desouki M.M., Fadare O., Chamberlain B.K., Shakir N., Kanbour-Shakir A.: ”Malignancy associated with ovarian teratomas: frequency, histotypes, and diagnostic accuracy of intraoperative consultation”. Ann. Diagn. Pathol., 2015, 19, 103.

[8] Kikkawa F., Nawa A., Tamakoshi K., Ishikawa H., Kuzuya K., Sug-anuma N., et al.: ”Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary”. Cancer, 1998, 82, 2249.

[9] Mori Y., Nishii H., Takabe K., Shinozaki H., Matsumoto N., Suzuki K., et al.: ”Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary”. Gynecol. Oncol., 2003, 90, 338.

[10] Paliogiannis P., Cossu A., Capobianco G., Sini M.C., Palomba G., Virdis G., et al.: ”Squamous cell carcinoma arising in mature cystic teratoma of the ovary: report of two cases with molecular analysis”. Eur. J. Gynaecol. Oncol., 2014, 35, 72.

[11] Choi E.J., Koo Y.J., Jeon J.H., Kim T.J., Lee K.H., Lim K.T.: ”Clinical experience in ovarian squamous cell carcinoma arising from mature cystic teratoma: A rare entity”. Obstet. Gynecol. Sci., 2014, 57, 274.

[12] Balık G., Ustüner I., Bedir R., Ural U.M., Kağıtçı M., Güven E.S.: ”Appendix and uterus metastasis of squamous cell carcinoma arising from mature cystic teratoma of the ovary”. Case Rep. Obstet. Gynecol., 2013, 2013, 474891.

[13] Armstrong D.K., Alvarez R.D., Bakkum-Gamez J.N., Barroilhet L., Behbakht K., Berchuck A., et al.: ”NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019”. J. Natl. Compr. Canc. Netw., 2019, 17, 896.

[14] Simone C.G., Markham M.J., Dizon D.S.: ”Chemotherapy in ovar-ian germ cell tumors: A systematic review”. Gynecol. Oncol., 2016, 141, 602.

[15] Nakamura Y., Kamei T., Shinagawa M., Sakamoto Y., Miwa I.: ”Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan”. J. Obstet. Gynaecol. Res., 2015, 41, 809.